BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raghu Subramanian C, Triadafilopoulos G. Care of inflammatory bowel disease patients in remission. Gastroenterol Rep (Oxf) 2016;4:261-71. [PMID: 27899522 DOI: 10.1093/gastro/gow032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Głąbska D, Guzek D, Gałązka K, Lech G. Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission. J Clin Med 2020;9:E771. [PMID: 32178368 DOI: 10.3390/jcm9030771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zheng XB, He XW, Zhang LJ, Qin HB, Lin XT, Liu XH, Zhou C, Liu HS, Hu T, Cheng HC, He XS, Wu XR, Chen YF, Ke J, Wu XJ, Lan P. Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice. Gastroenterol Rep (Oxf) 2019;7:127-38. [PMID: 30976426 DOI: 10.1093/gastro/goy017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
3 Baradaran Ghavami SH, Shahrokh SH, Hossein-Khannazer N, Shpichka A, Asadzadeh Aghdaei H, Timashev P, Vosough M. IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False? Cell J 2020;22:151-4. [PMID: 32779446 DOI: 10.22074/cellj.2020.7603] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Nielsen AS, Appel CW, Larsen BF, Hanna L, Kayser L. Digital patient-reported outcomes in inflammatory bowel disease routine clinical practice: the clinician perspective. J Patient Rep Outcomes 2022;6:52. [PMID: 35587297 DOI: 10.1186/s41687-022-00462-x] [Reference Citation Analysis]